AI-Driven Drug Design: Accelerating Healthcare Innovation through Advanced Molecular Simulations

This project combined expertise in AI and biotech to speed up drug discovery and healthcare diagnostics. Created AI agents capable of simulating molecular interactions and analyzing biomarkers for precision medicine and also for new drug candidates, antibody. Using scientific machine learning tools in identifying drug candidates and personalizing treatment strategies. This endeavor strengthened understanding of integrating AI into healthcare systems for better patient outcomes. It also showcased capability to bridge computational science with real-world medical applications.